1 0 5 1 a r t i c l e s The retinoblastoma tumor suppressor protein (Rb) regulates the cell cycle through its capacity to associate with and influence the function of a number of cellular proteins. In the best-characterized example, Rb binds and inhibits E2F transcription factors to coordinate the initiation of S phase with mitogenic signaling 1,2 . Rb activitynamely, its competency to bind E2F-is regulated by phosphorylation in a cell cycle-dependent manner. In G0 and early G1, Rb is active and modified at relatively few phosphorylation sites. In this hypophosphorylated state, Rb sequesters E2F and recruits transcriptional corepressors and chromatin-modifying enzymes to E2F-responsive promoters to block transcription 1,3-6 . Hyperphosphorylation of Rb by cyclin-dependent kinases (Cdks) from late G1 until mitosis inactivates Rb by dissociating these factors and results in the expression of genes required for DNA synthesis and cell-cycle progression 1,7,8 . The enzyme protein phosphatase 1 (PP1), which is required for mitotic exit and is responsible for reversing the phosphorylation of many Cdk substrates, dephosphorylates Rb beginning in anaphase 9-11 . PP1-dependent Rb dephosphorylation has also been observed during S and G2 in response to hypoxia and DNA damage, suggesting that it is also responsible for Rb activation under these conditions 12, 13 . The importance of phosphorylation for regulating Rb activity as a tumor suppressor is underscored by the fact that genes encoding cyclin D and p16 are frequently mutated in cancers, leading to constitutive Rb hyperphosphorylation 14, 15 .
a r t i c l e s
The retinoblastoma tumor suppressor protein (Rb) regulates the cell cycle through its capacity to associate with and influence the function of a number of cellular proteins. In the best-characterized example, Rb binds and inhibits E2F transcription factors to coordinate the initiation of S phase with mitogenic signaling 1, 2 . Rb activitynamely, its competency to bind E2F-is regulated by phosphorylation in a cell cycle-dependent manner. In G0 and early G1, Rb is active and modified at relatively few phosphorylation sites. In this hypophosphorylated state, Rb sequesters E2F and recruits transcriptional corepressors and chromatin-modifying enzymes to E2F-responsive promoters to block transcription 1,3-6 . Hyperphosphorylation of Rb by cyclin-dependent kinases (Cdks) from late G1 until mitosis inactivates Rb by dissociating these factors and results in the expression of genes required for DNA synthesis and cell-cycle progression 1, 7, 8 . The enzyme protein phosphatase 1 (PP1), which is required for mitotic exit and is responsible for reversing the phosphorylation of many Cdk substrates, dephosphorylates Rb beginning in anaphase [9] [10] [11] . PP1-dependent Rb dephosphorylation has also been observed during S and G2 in response to hypoxia and DNA damage, suggesting that it is also responsible for Rb activation under these conditions 12, 13 . The importance of phosphorylation for regulating Rb activity as a tumor suppressor is underscored by the fact that genes encoding cyclin D and p16 are frequently mutated in cancers, leading to constitutive Rb hyperphosphorylation 14, 15 .
Mechanisms for regulating Rb phosphorylation have focused on the modulation of Cdk activity 1, 2, 16 . Although levels of Rb phosphorylation in the cell cycle generally coincide with levels of Cdk activity, there are circumstances, such as during mitotic exit and after DNA damage, in which Rb must be actively dephosphorylated and maintained in a hypophosphorylated state. In fact, several cancer lines have been shown to be defective in activating Rb by dephosphorylation 17 . Therefore, an important mechanistic question remains regarding how phosphatase activity opposes kinase activity to control Rb phosphorylation. A stable PP1-Rb complex has been observed that is coincident with the timing of dephosphorylation in mitosis 18 . Nevertheless, compared to Cdks, much less is known regarding how PP1 recognizes Rb and how Rb dephosphorylation may be regulated.
In cells, PP1 activity typically arises from a complex containing the catalytic subunit (PP1c) and a variable regulatory subunit; the latter confers substrate specificity and enhances activity 19 . There are three mammalian isoforms of PP1c; the isoforms all contain the highly conserved catalytic domain and only differ in their unstructured N and C termini 19, 20 . Nearly all regulatory subunits and many inhibitors contain a consensus Arg-Val-x-Phe (RVxF) sequence, which binds PP1c at a site distinct from the catalytic site [19] [20] [21] . Endogenous Rb-PP1 complexes copurify with other proteins, and an interaction between Rb and the myosin phosphatase-targeting subunit has been reported 22, 23 ; these observations suggest the existence of a regulatory subunit for Rb dephosphorylation. In contrast, there have been several reports of a direct, functional complex between Rb and all three PP1c isoforms without the requirement of a targeting subunit 24, 25 . Thus, the mechanism of Rb-specific PP1 activity remains unclear.
Rb contains two structured domains known as the N-terminal and pocket domains as well as a C-terminal domain (RbC) of ~150 residues ( Fig. 1a) . RbC is necessary and sufficient for observation of an Rb-PP1c complex in cell extracts for all three PP1c isoforms 24, 25 . RbC is intrinsically disordered but adopts structure upon binding E2F-DP heterodimers 26 (Supplementary Fig. 1 ). Other proteins that have been shown to associate with RbC include cyclins, Skp2, c-Abl and MDM2 (refs. 27-30) . In the case of cyclin A (CycA), a crystal structure 1 0 5 2 VOLUME 17 NUMBER 9 SEPTEMBER 2010 nature structural & molecular biology a r t i c l e s reveals that a short Rb 868-878 peptide docks to the structured CycA domain in an extended conformation 31 . This sequence contains the canonical Arg-x-Leu (RxL) sequence motif that targets Cdk-cyclins to Rb and other substrates for efficient phosphorylation 27, 32 . At present, little is known about whether these RbC binding partners are capable of interacting with Rb simultaneously or competitively, leaving their regulatory impact on Rb uncharacterized.
We examine here the RbC-PP1c association in molecular detail to understand the mechanism of Rb activation by dephosphorylation. We find that human PP1c uses its regulatory subunit-binding cleft to dock with an RVxF-like motif in RbC. The PP1c binding sequence overlaps with the previously identified RxL cyclin binding site, and the association of Rb with PP1c and Cdk-cyclin is exclusive. These results reveal an efficient regulatory mechanism, generally applicable in cell signaling, in which phosphatase and kinase activities affect phosphorylation state not only through catalysis but also through restricting access to their target substrate.
RESULTS

Rb 870-882 is necessary and sufficient for PP1c association
To determine the precise sequence requirements for RbC-PP1c binding, we applied isothermal titration calorimetry (ITC) to quantitate binding affinity. We titrated recombinant, purified Rb proteins into recombinant PP1c (α-isoform), and we calculated dissociation constants from the resulting isotherms ( Fig. 1) . We first determined that Rb 55-928 , which contains all of the conserved Rb domains and phosphoacceptor sites, binds PP1c with K d = 3.9 ± 0.2 μM (Fig. 1b,c) . This value is typical for enzyme-substrate binding interactions and is similar to that previously observed between an RbC peptide and CycA 31 .
We next made a series of truncation mutants and tested the affinity of these mutants for PP1c by calorimetry ( Fig. 1c and Supplementary  Fig. 2 ). Rb 771-928 and Rb 866-928 bind PP1c with similar affinity to that of full-length Rb, which is consistent with previous reports that RbC is sufficient for the association and phosphorylation is not required 24, 25, 33 . Titration of Rb 889-928 into PP1c results in no detectable heat signal, indicating that the conserved residue sequence between 866 and 889 is required for binding. Using a synthetic peptide, we found that Rb 870-882 binds PP1c with comparable affinity (K d = 1.2 ± 0.4 μM) to that of full-length Rb, confirming that Rb 870-882 is necessary and sufficient for PP1c association and likely contains all of the significant interacting residues. This conserved sequence contains the CycA docking site and a Lys-Leu-Arg-Phe (KLRF) sequence that resembles the consensus RVxF motif found in PP1 regulatory subunits ( Supplementary Fig. 1 ).
Crystal structure of Rb 870-882 -PP1c
We next crystallized and solved the structure of a complex of the α-isoform of PP1c with an Rb 870-882 peptide ( Table 1 Fig. 3 ). The structure of PP1c in the complex is essentially identical to that observed in both the PP1cmicrocystin and PP1c-tungstate complexes 33, 34 . The Rb peptide binds PP1c in an extended conformation at the hydrophobic interface of the core β-sandwich subdomain opposite the catalytic site ( Fig. 2a) . Rb binding is mediated both by main chain hydrogen bonding and a r t i c l e s hydrophobic side chain interactions (Fig. 2b,c) . Arg876-Asp878 of Rb form a short β-strand that adds to sheet 1 of the PP1c β-sandwich subdomain. The Rb β-strand makes hydrogen bonding interactions with the edge strand of the sheet that are typical of parallel strandstrand interactions.
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The other significant interactions between the Rb peptide and PP1c are made by the highly conserved hydrophobic side chains of Leu875 and Phe877 ( Fig. 2c and Supplementary Fig. 1) . Each inserts into a pocket within the hydrophobic core of the β-sandwich subdomain of PP1c. The PP1c β-sandwich structure and the specific side chains that contact RbC are conserved in all three mammalian isoforms of the enzyme (Supplementary Fig. 4 ). Thus, our structural data are consistent with and explain the previous observation that all of the PP1c isoforms bind Rb 25 . Furthermore, the observation that RbC contacts PP1c at a site that is distinct from the phosphatase active site explains the observation that catalytic activity of PP1c is not required for Rb-PP1 association 35 .
The location of the Rb peptide binding site in PP1c and the molecular interactions stabilizing the complex are nearly identical to those observed between PP1c and the RVxF motif of two PP1 targeting subunits 20, 21 . In the structure of the myosin phosphatase subunit 1 (MYPT1) bound to PP1c (isoform δ) ( Supplementary Fig. 5 ), Lys37-Asp39 of MYPT1 add to the PP1c sandwich domain as a parallel β-strand, and Val36 and Phe38 of MYPT1 insert into the same hydrophobic pockets of PP1c as observed here for Leu875 and Phe877 of Rb 20 . Notably, the occurrence of leucine in RVxF motifs is extremely rare, and mutation of the canonical valine to leucine sometimes abolishes docking motif binding 36 . However, the similarity of contacts by RbC and MYPT1 with PP1 shows that the KLRF sequence at residues 874-877 of Rb functions as an RVxF motif.
It is noteworthy that Leu875 and Phe877 in RbC also bind to hydrophobic pockets in CycA ( Supplementary Figs. 1 and 5) 31 . Leu875 is the leucine in the Rb RxL motif that is required for its phosphorylation 27, 31, 32 . Phe877 is buried along with Leu875 in the RbC-Cdk2-CycA structure, and both appear critical for stabilizing the observed docking interaction between kinase and substrate 31 . We found that mutation of these hydrophobic residues results in a loss of RbC affinity for PP1c and Cdk2-CycA (Supplementary Methods and Supplementary Fig. 2) . These experiments verify that Leu875 and Phe877 are part of an enzyme-docking site in RbC required for association with both enzymes.
The Rb paralogs p107 and p130 also contain RxL sequences that are critical for binding to Cdk2-CycA 31, 32 . However, unlike Rb, the phenylalanine in both the p107 and p130 docking motifs directly follows the leucine (Arg-Arg-Leu-Phe (RRLF)). We found that the CycA binding motifs in both pocket proteins (p107 655-667 and p130 677-689 ) do not also bind PP1c (Supplementary Fig. 2 ). This result is consistent with the crystal structure, which reveals that leucine forms critical contacts with PP1c in the −2 position (relative to the phenylalanine).
PP1c docking is required for efficient RbC dephosphorylation
To examine the effects of the Rb-PP1c association on Rb-directed PP1 phosphatase activity, we developed an assay to measure Rb dephosphorylation rates. We quantitatively phosphorylated two RbC constructs, both containing seven Cdk consensus sites ( Fig. 3a) , with 32 P. After mixing substrate with phosphatase, signal intensity remained at longer time points in phosphorylated Rb 771-874 (phosRb 771-874 ) compared to phosRb 771-928 ( Fig. 3b) , indicating that deletion of the PP1c docking site in RbC results in a loss of dephosphorylation efficiency. Quantification of the signal indicates that the first-order rate constant for dephosphorylation of phosRb 771-874 (k dephos = 0.027 ± 0.002 min −1 ) is approximately eight times smaller than for phosRb 771-928 (k dephos = 0.20 ± 0.01 min −1 ) ( Fig. 3c) . We also found that a short peptide containing the KLRF sequence inhibits phosRb 771-928 dephosphorylation when added to the assay, further confirming that the docking site permits more efficient substrate processing ( Supplementary Fig. 6 ). Analogous phosphatase assays with mutant phosRbC fragments a r t i c l e s that contain only one pair of phosphorylated sites show that dephosphorylation occurs at all of the sites with kinetics that are sensitive to the presence of the PP1c docking site (Supplementary Fig. 7) . We performed phosphatase assays at different substrate concentrations to determine apparent steady-state kinetic parameters for dephosphorylation of the multiple RbC sites (Fig. 3d) . The apparent k cat for dephosphorylation of phosRb 771-874 (k cat = 140 ± 20 min −1 ) and of phosRb 771-928 (k cat = 160 ± 20 min −1 ) are similar. However, the apparent K M for phosRb 771-874 (K M = 30 ± 10 μM) is greater than the apparent K M of phosRb 771-928 (K M = 6 ± 3 μM). These results are consistent with the RbC KLRF docking sequence enhancing dephosphorylation by enabling PP1c to capture substrate and form an enzyme-substrate complex.
We next examined how mutations in the overlapping PP1c and Cdk-cyclin docking site affect enzyme activity toward Rb. In the phosphatase assay, dephosphorylation of Rb 771-928 that contains an F877A mutation (k dephos = 0.071 ± 0.004 min −1 ) is slower than wild type (k dephos = 0.29 ± 0.03 min −1 ) ( Fig. 3e) . Switching the position of the phenylalanine and arginine (R876F F877R) in Rb 771-928, which creates a docking sequence that more resembles P107 and P130, also results in a smaller first-order rate constant in the assay (k dephos = 0.067 ± 0.006 min −1 ).
To test these mutants in a kinase assay, we prepared complexes of RbC and E2F1-DP1 to mimic the physiological, active Rb substrate. In binding assays, the presence of E2F1-DP1 does not affect appreciably the affinity of either PP1c or Cdk2-CycA for RbC ( Supplementary Fig. 2) , indicating that the E2F-DP binding site in RbC does not overlap with the common enzyme-docking site. The first-order rate constant characterizing phosphorylation of wild-type RbC (k phos = 0.023 ± 0.001 min −1 ) is greater than that for the F877A mutant (k phos = 0.011 ± 0.001 min −1 ) ( Fig. 3f ). This measured kinetic difference is consistent with the Lys-x-Leu-x-Phe (KxLxF) motif at 873-877 in Rb being required for phosphorylation by Cdk2-CycA 27 . The R876F F877R mutant (k phos = 0.024 ± 0.001 min −1 ) has a first-order rate constant similar to that of wild type. This observation follows previous findings that Cdk2-CycA is capable of docking to both K/RxLxF (Rb-like) or K/RxLF (p107-like) sequences 31 . Our kinetic studies of docking-site mutants show that both PP1c and Cdk-cyclin utilize an overlapping docking site in Rb and indicate that the R876F F877R mutant is defective as a PP1 substrate but not as a Cdk substrate.
PP1 inhibits Cdk2-CycA activity toward Rb
Considering that both kinase and phosphatase cannot bind the required docking site together, we hypothesized that each enzyme would act as an inhibitor of the other by occluding the site. We first tested whether inactive PP1c could inhibit the phosphorylation of RbC by Cdk2-CycA in the kinase assay (Fig. 4) . In the absence of PP1c, the first-order rate constant for Rb 771-928 phosphorylation (k phos = 0.0185 ± 0.0001 min −1 ) was 11 times greater than that for Rb 771-874 phosphorylation (k phos = 0.0017 ± 0.0001 min −1 ). We then carried out kinase reactions in the presence of saturating quantities of PP1c that was irreversibly inhibited at its catalytic site with microcystin ( Fig. 4) . The presence of PP1c-microcystin reduces the rate constant for Rb 771-928 phosphorylation (k phos = 0.0051 ± 0.0001 min −1 ) such that it is more similar to the rate constant for Rb 771-874 phosphorylation. By contrast, PP1c-microcystin has little effect on Rb 771-874 phosphorylation (k phos = 0.0013 ± 0.0001 min −1 ). Thus, our data indicate that PP1c directly inhibits RbC phosphorylation by Cdk2-CycA and that inhibition is independent of phosphatase activity and dependent on the presence of the KLRF docking site. We have also found, using the phosphatase assay, that Cdk2-CycA inhibits RbC-directed PP1c phosphatase activity (Supplementary Fig. 8 ).
Inhibition of Cdk access to Rb blocks cell-cycle progression
Having established that Cdk and PP1c compete for Rb access, we investigated the functional importance of this competition in the context of cell-cycle regulation. The human osteosarcoma cell line Saos-2 is deficient for Rb, and Rb re-expression leads to a strong G1 arrest 37 . Coexpression of Cdk2-CycA abrogates this arrest through phosphorylation and inactivation of Rb 38, 39 . We used this model system to observe the effect of PP1 on Cdk regulation of Rb (Fig. 5a) . We found that the Rb-induced arrest was overcome by Cdk2-CycA expression, and it could be largely recovered by expressing PP1c. Notably, coexpression of a catalytically inactive mutant of PP1c (PP1c H248K) also resulted in a restoration of G1 arrest. Omission of Rb from these assays abrogated the PP1c-dependent cell-cycle block, confirming that Rb is the relevant target of enzyme competition. In Figure 5b , the expression levels of PP1c were titrated and reveal that catalytically inactive enzyme is as potent as wild type in blocking cellcycle advancement under conditions in which Rb expression has been reduced. Based on these cell-cycle control data, we conclude that the competition for substrate access between Cdk2-CycA and PP1c on Rb offers an efficient means to control cell proliferation beyond the catalytic regulation of phosphorylation.
We next confirmed that PP1c inhibits phosphorylation of Rb in cells, as in our kinetic analyses, in a manner that is independent of catalytic activity. We used C33A cells to test whether exogenously introduced PP1c could compete with Cdks and block Rb phosphorylation regardless of cell-cycle position effects on enzyme activity (Fig. 5c) . Ectopically expressed Rb becomes phosphorylated in C33A cells. Expression of a dominant negative Cdk2 controls for inhibition of Rb phosphorylation in our analysis, and coexpression of Rb with Cdk2-CycA shows the maximum extent of Rb hyperphosphorylation. a r t i c l e s As predicted, expression of PP1c or catalytically dead PP1c H248K inhibited Rb phosphorylation levels in a dose-dependent manner.
Our kinetic data indicate that the Rb R876F F877R mutant is a poor PP1 substrate but a good Cdk substrate. We used this mutation to study the importance of the docking site for dephosphorylation and Rb activation in cell-based assays. First, we transfected wild-type Rb and Rb R876F F877R into C33A cells with and without also transfecting PP1c (Fig. 5d) . Coexpression of PP1c reduces the observed phosphorylation of wild-type Rb (migrates as a faster, single band), whereas the mutant Rb R876F F877R is unaffected by phosphatase expression. This observation suggests that the docking interaction observed in our crystal structure is required in cells for efficient Rb dephosphorylation by PP1.
We also tested the Rb R876F F877R mutant in the Saos-2 cell-cycle arrest assay. Expression of Rb R876F F877R in Saos-2 cells gives a less robust arrest in G1 compared to wild type, consistent with the idea that Rb activation requires docking-dependent PP1c dephosphorylation that is defective in this mutant (Fig. 5e ). Cdk2-CycA expression still inactivates Rb R876F F877R as expected because the kinase-docking site remains intact. We also find that, under conditions in which Rb and kinase are expressed, coexpression of PP1c is sufficient to restore the activity of wild-type Rb but is unable to reactivate phosphorylated Rb R876F F877R (Fig. 5f) . Taken together, these data highlight a critical role for the KLRF docking site in the regulation of Rb activity.
Stable Rb-PP1 complexes are coincident with Rb activation
The competition for access to Rb between PP1c and Cdk-cyclin suggests that Rb and PP1c are in a complex at times when Rb is activated by dephosphorylation. To investigate the relevance of this mechanism of cell-cycle regulation under endogenous conditions, we examined the abundance of Rb-PP1c complexes in CV-1 cells during mitotic exit and transfected Saos-2 cells that arrest in a PP1-dependent manner in early G1 (Fig. 6) . We used CV-1 cells because synchronization experiments have shown that PP1 and Rb associate selectively in late mitosis, coincident with Rb dephosphorylation and activation in these cells 18 . We first compared the relative level of the endogenous proteins in CV-1 cells with the level of transfected proteins in Saos-2 cells by applying recombinant standards (Fig. 6a) .
We found that the molar quantities of Rb in extracts from CV-1 and Saos-2 transfected cells were equivalent. Considering that the majority of Saos-2 cells are transfected in our experiments, the Rb expression level in the Saos-2 cells is no more than 2 times higher. The levels of PP1c in mitotic CV-1 cells were a little less than half as much as those of Rb, whereas the total levels of endogenous and exogenously introduced PP1c in arrested Saos-2 cells were approximately equivalent to those of Rb. These observations indicate that our transfection-based assay system closely mimics the levels of endogenous proteins under conditions where Rb is activated. a r t i c l e s We next immunoprecipitated Rb complexes from CV-1 and transfected Saos-2 cells and immunoblotted for bound PP1c (Fig. 6b) . The amount of PP1 coprecipitated from arrested Saos-2 cells is ~30% of the total amount of immunoprecipitated Rb, indicating that onethird of Rb molecules are bound to PP1c when cells are arrested in a PP1-dependent manner. The amount of PP1c coprecipitated with Rb in CV-1 cells is ~2%; however, given that the population of CV-1 cells is actively progressing through mitosis and the limitations of synchronization by shakeoff, this measurement likely underestimates the quantity of Rb-PP1c complex that exists in a cell at the instant of Rb activation. Taken together, these experiments suggest that PP1 can form stable, abundant complexes with Rb at endogenous expression levels. These complexes attenuate the activity of Cdks by blocking their access to Rb and regulate progression through the cell cycle.
DISCUSSION
Although much attention has been paid to the inactivation of Rb by Cdk phosphorylation from G1 through mitosis, less is known regarding how Rb is activated by PP1 dephosphorylation during mitotic exit and following cellular stress. We have identified a short sequence in RbC that binds to PP1c directly and is required for efficient Rb-directed PP1 phosphatase activity. Our structural data show that the molecular interactions stabilizing RbC-PP1c are nearly identical to those observed between PP1c and its regulatory subunits. Whereas PP1c typically uses its hydrophobic binding cleft to recruit an additional subunit responsible for substrate binding, here PP1c uses the cleft to recruit Rb substrate directly 20, 21 . Although uncommon, a direct interaction between PP1c and the PP1 substrate Cdc25 has also been observed in Xenopus laevis embryonic extracts 40 . Recent data indicate that PP1c dissociates from inhibitors following Cdk inactivation during mitosis 9 . The timing of this population of free PP1c is concurrent with the requirement to dephosphorylate Rb through a direct interaction, and it would be interesting to explore whether other PP1 substrates are dephosphorylated at mitotic exit without a targeting subunit.
The fact that the direct enzyme-substrate association is mediated through the 'RVxF'-binding cleft may explain why an Rb-targeting regulatory subunit has not been identified and is not necessary for Rb dephosphorylation 25 . Although the existence of such a subunit cannot be ruled out, our data indicate that both Rb and a hypothetical Rb-targeting subunit could not both occupy the RVxF-binding cleft and that a different mode of Rb-PP1 holoenzyme assembly would be required. However, considering that multiple phosphates in varying sequence contexts must be hydrolyzed in Rb, it seems reasonable that the Rb phosphatase would not use a targeting subunit to impart a high degree of specificity. RbC closely mimics regulatory subunits in PP1 binding, and it is also tempting to speculate that Rb itself is a PP1 regulatory subunit, either sequestering nuclear PP1c from other activating subunits or regulating PP1c access to other substrates. Notably, it has been reported that RbC can act as a noncompetitive inhibitor of PP1c activity toward a generic substrate 35 .
Our data, together with previous results, indicate that PP1c and Cdk2-CycA bind an overlapping docking site in RbC that is required in each case for efficient enzymatic activity 27, 31 . To our knowledge, this observation is the first example of a PP1c-binding sequence (RVxF or other) having an additional functional role that competes with PP1 activity. As a result of their exclusive associations with substrate, we have shown that Cdk2-CycA and PP1c can each directly inhibit the activity of the other enzyme toward Rb. This result reveals a novel mechanism for the regulation of Rb phosphorylation state in which kinase and phosphatase compete for access to substrate. Given the conservation of the RxL binding cleft in cyclin paralogs, it is assumed that the observed competition would exist between PP1 and all Cdk-cyclins that phosphorylate Rb. In contrast, the other Rb family proteins p107 and p130 do not bind PP1c; this competitive mechanism is unique to Rb.
Competition between kinase and phosphatase for controlling the phosphorylation state of a common substrate has been established as an important mechanism in cell signaling, and a theoretical framework has been crafted for how such competition can generate critical signaling properties such as sensitivity, switch-like responses and multiple steady-state outputs [41] [42] [43] [44] . However, few experimental observations of these properties have been reported. Our finding of a Cdk-cyclin competition with PP1c for Rb as a substrate not only provides a rare example of direct kinase-phosphatase competition but also shows that competition can be for substrate docking as well as catalysis. Notably, the presence of common kinase/phosphatase docking sites in mitogen-activated protein kinases has been observed 45 , suggesting that competition for substrate binding may have a more general role in signal transduction.
In the context of Rb phosphorylation in cell-cycle control, signaling sensitivity and specificity are critical. From mitosis through G1, the capacity of PP1c to inhibit Cdk-cyclin could facilitate efficient Rb dephosphorylation in response to small changes in PP1c concentration and could prevent Rb from being promiscuously rephosphorylated by residual Cdk activity. The same holds true in response to cellular stress and cell-cycle exit, and in fact, it has been shown that Rb is dephosphorylated in response to DNA damage despite the presence of active Cdks 13 . These regulatory concepts that would serve to activate Rb are supported by our cell-cycle arrest assays. Therefore, our findings establish a biochemical mechanism through which Rb phosphorylation and function can be tightly controlled in the cell by directly competing kinase and phosphatase activities. Further study is necessary to determine what mechanisms influence the outcome of a r t i c l e s the competition and how access of each enzyme to the docking site is controlled. Considering the observation that the association between Rb and PP1c is direct, the nuclear concentration of PP1c, free of inhibitors and other targeting subunits, is an intriguing possible factor.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/. Phosphatase and kinase assays. Purified Cdk2-CycA was first activated by phosphorylation in a reaction containing 10% (w/w) GST-Cak, 10 mM MgCl 2 and 5 mM ATP. To prepare for the phosphatase assays, 1 mg of RbC was incubated with 0.25 mg of activated Cdk2-CycA for 1 h at room temperature in a buffer containing 50 mM HEPES, 100 mM NaCl, 10 mM MgCl 2 , 1 mM ATP and 5 μCi of 32 P-labeled ATP (pH 7.5). These reaction conditions give nearly quantitative phosphorylation of Cdk consensus sites in RbC 48 . Reactions were quenched by addition of 8 M urea, and phosRbC was isolated with a nickel-nitrilotriacetic acid spin column (Qiagen). Phosphatase reactions were carried out at room temperature in a buffer containing 50 mM HEPES, 100 mM NaCl and 2 mM MnCl 2 (pH 7.5). Reactions were initiated by addition of enzyme. Aliquots were removed at the indicated time point and quenched by mixing with SDS-PAGE loading buffer.
For the phosphatase steady-state analysis, dephosphorylation assays were carried out at varying substrate concentrations. The initial rate at each concentration was determined from a linear fit of band intensities of the first 3 or 4 time points, and the corresponding fitting errors were assigned as the error of each rate measurement. Initial rates were fit as a function of substrate concentration with a simple Michaelis-Menten model to calculate the effective K M and k cat.
For kinase assays, 75 nM activated (phosphorylated with CAK) Cdk2-CycA, 20 μM E2F1-DP1 and 2 μM RbC substrates were mixed in a reaction at room temperature containing the kinase buffer described above and 20 μCi of 32 P-labeled ATP (pH 7.5). In kinase reactions with PP1c, PP1c was first inactivated by mixing in a 1:3 molar ratio with L,R-microcystin. An additional 25 μM microcystin was present in the competition reactions to ensure no residual PP1c activity (the IC 50 for microcystin is ~1 nM). Phosphorimaging was done with a Typhoon Trio gel scanner (Amersham) and data was analyzed with the ImageQuant software package (Molecular Dynamics). Kinetic data were fit with a first-order rate law using Kaleidagraph (Synergy Software). The reported error of each kinetic parameter is the fitting error.
Cell-cycle arrest experiments. We transfected 1 × 10 6 proliferating Saos-2 cells with 0.75 μg of CMV-Rb (0.5 μg in Fig. 5b ), 1 μg of CMV-CD20 (used to mark transfected cells in flow cytometry analysis) and 6 μg of CMV-bGal, using Fugene 6 (Roche). Where indicated, 1 μg of CMV-HA-cdk2, 1 μg of CMV-CycA and 4 μg of CMV-myc-PP1c were added, and the appropriate amount of CMV-bGal was omitted to maintain uniform DNA concentrations. We analyzed cells 3 d following transfection by flow cytometry as described previously 49 .
C33A cells were transfected with 10 μg of CMV-Rb, 2.5 μg of CMV-HA-cdk2, 2.5 μg of CMV CycA and 2.5 to 10 μg of CMV-myc-PP1c; CMV-βGal was included where necessary to obtain a final quantity of 25 μg. Transfections were performed by Ca 2 PO 4 precipitation. Cells were harvested after 2 d, and nuclear lystates were prepared for SDS-PAGE and western blotting as described 50 . Rb was detected with monoclonal antibody G3-245 (BD Pharmingen) and antiphosphoserine 807/811 antibodies from Cell Signaling.
For immunoprecipitation experiments, extracts were prepared as described above from Saos-2 cells transfected with Fugene HD (Roche). CV-1 cells were isolated by mitotic shakeoff from cultures that were first blocked in S phase with 2.5 mg ml −1 aphidicolin for 24 h then released for 16 h to enrich for mitotic cells. Immunoprecipitations were carried out using monoclonal antibody Rb4.1 (Developmental Studies Hybridoma Bank, University of Iowa) against Rb. Extracts and immunoprecipitated proteins were analyzed by SDS-PAGE alongside recombinant PP1c and GST-Rb 380-928 controls. Rb and PP1 were detected on western blots by Rb4.1 and sc-7482 (Santa Cruz), respectively. Standard curves to determine protein quantities were generated by using ImageJ software (US National Institutes of Health) to quantitate band intensities.
